Skip to main content
Premium Trial:

Request an Annual Quote

BD's MRSA Assay Receives Moderate Complexity Rating Under CLIA

NEW YORK (GenomeWeb News) – Becton Dickinson segment BD Diagnostics said today its BD Max MRSA molecular test has received a Moderate Complexity rating under the Clinical Laboratory Improvement Amendments of 1988.

The rating allows the test to be performed by a qualified laboratory technician.

The assay was cleared by the US Food and Drug Administration last month for marketing in the US. It runs on the fully automated BD Max System and was developed to rapidly identify patients with methicillin-resistant Staphylococcus aureus.

"Healthcare institutions can now simplify and optimize their MRSA active surveillance testing in less than a minute of hands-on time per specimen with true walk-away automation," Tom Polen, president of BD Diagnostics, said in a statement.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.